Simplifying Global Compliance
ANDA Sponsors’ Tablets Should Be Close to RLD in Size, Shape
Washington Drug Letter
Generics makers should design tablets and capsules to be similar in size and shape to their reference listed drug (RLD) when they seek ANDA approval, the FDA says.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing